Background: Time-lapse monitoring (TLM) technology has been implemented in the clinical setting for the culture and selection of human embryos. Many studies have assessed the association between sperm DNA fragmentation (sDNAf) and clinical outcomes after ART, but little is known about the influence of sDNA on embryo morphokinetics. Objectives: The objective of this retrospective study, which includes 971 embryos from 135 consecutive ICSI cycles (56 cases with own oocytes, 79 with oocytes from young and healthy donors), was to assess if sDNAf has an impact on embryo morphokinetics. Materials and methods: Samples used to perform ICSI were analyzed by the flow cytometry TUNEL assay, and embryo development was assessed through an EmbyoScope â system. The association between sDNAf and the timings of cell cleavage was analyzed
INTRODUCTION
Over the past decade, there has been a growing body of research focused on the role of sperm DNA integrity in male factor infertility. Sperm DNA fragmentation (sDNAf) testing has been used to assess such integrity. Its stability on the same individual over time is documented (Sergerie et al., 2006) , and it has also been associated with infertility (Sergerie et al., 2005) both in the presence (Lopes et al., 1998) (Cohen-Bacrie et al., 2009 ) and absence of abnormalities in conventional sperm parameters (Saleh et al., 2002) .
Many studies have assessed the association between sDNAf test results and pregnancy probability in IVF and ICSI cycles (Evenson & Wixon, 2006) (Li et al., 2006) (Cissen et al., 2016 However, doubts persist regarding the best technique to quantify it, its pathological threshold value, and its impact on ART outcomes. For example, it remains controversial whether in vitro embryos derived from ejaculates with a high rate of sDNAf are of lower quality based on conventional parameters (Benchaib et al., 2003) and the literature on the effect of sDNAf on embryo morphokinetics is still scarce. While Hambilik et al. correlated higher sDNAf with slower embryos in ICSI cycles and faster embryos in IVF cycles (Hambilik, 2016) , Wdowiak et al. (2015) observed that lower sDNAf levels were associated with embryos that reached the blastocyst stage at a faster rate.
The lack of consensus could be explained by the method of assessment, the performance of the test before or after sperm preparation, patients' inclusion criteria, and heterogeneity in the oocyte capacity to repair sDNAf (Marchetti et al., 2007) . On the other hand, the most consistent finding is the increased frequency of early pregnancy loss when embryos are generated from spermatozoa with high DNA damage (Zini et al., 2008) (Robinson et al., 2012) (Ribas-Maynou et al., 2012) . This indicates that ART outcome may be negatively influenced by sDNAf at a later stage.
Under normal circumstances, DNA damage in spermatozoa is the consequence of the persistence of unresolved DNA nicks from the chromatin remodeling that occurs during spermiogenesis (Aitken et al., 2013) . Other factors proposed to induce DNA damage in human spermatozoa are as follows: poor or abnormal chromatin packaging (Manicardi et al., 1995) (McPherson & Longo, 1992) (Zhao et al., 2004) , programmed cell death aiming to eliminate defective germ cells (Sakkas et al., 1999) , and oxidative stress caused by the overproduction of reactive oxygen species (ROS) (due to the exposure to xenobiotics or to radiofrequency radiation, scrotal heat stress, infections, and advanced paternal age, among others) (Aitken & De Iuliis, 2007) .
Spermatozoa have no mechanism to repair DNA damage that occurs during the passage through the epididymis or post-ejaculation (Aguilar et al., 2010) , DNA-repairing activity relies on the oocyte machinery once fertilization takes place, which is carried out by the zygote (Fern andez-D ıez et al., 2015) (Brandriff & Pedersen, 1981) . In fact, the maternal transcripts and proteins support the zygote's development until embryonic genome activation. The ability of the oocyte to repair DNA damage in the fertilizing spermatozoon will depend not only on the level and type of sperm chromatin damage, but also on the quality of the female germ cell repair machinery (Gonz alez-Mar ın et al., 2012). It is clear that with increasing maternal age the amount of mRNA stored in oocytes decreases, as does their efficacy to repair the DNA (Hamatani et al., 2004) .
Advanced maternal age (AMA), defined as childbearing in a woman over 35 years of age, is a growing trend within highincome countries. Increasing maternal age has a well-established negative effect not only on fertility, reproductive success, and offspring fitness (Belloc et al., 2008) (Maheshwari et al., 2008) , but also on embryo development and IVF outcomes (Thum et al., 2008) (Liu & Allison, 2011) . The age-related decline in female fertility may be reversed using donated oocytes from a younger woman, and women of advanced reproductive age may give birth to infants with success rates similar to those of their younger counterparts using assisted reproductive methods (Sauer et al., 1992) . Furthermore, egg donation from vitrified oocytes banks is an increasingly common treatment modality because it produces similar clinical outcomes when compared to fresh cycles (Cobo et al., 2010) .
After the safety of time-lapse monitoring (TLM) technology was demonstrated for human embryos (Cruz et al., 2011) , morphokinetics systems began to be implemented in the clinical setting for culture and selection. TLM enables nearly continuous monitoring of embryo development through frequent multiple image acquisitions without potentially compromising viability due to the interruption of culture conditions (Wong et al., 2013) . Several authors have proposed the use of kinetic markers for improving embryo selection, and some algorithms have been elaborated to complement embryo morphology assessment. TLM algorithms have been successfully used to predict blastocyst formation (Wong et al., 2010) , embryo aneuploidy (Chavez et al., 2012) (Campbell et al., 2013) , and embryo implantation (Adamson et al., 2016) . Moreover, some adverse events that could not be monitored with conventional observation have been identified. Some of these events have been described in a consensus document (Ciray et al., 2014) created with the aim of allowing practitioners to improve the interpretation and sharing of data. Abnormal cleavage patterns include trichotomous, incomplete or asynchronous cleavage, and fusions. It is yet to be established the degree to which viability is compromised in embryos suffering such adverse events, although extremely low implantation rates have been reported when the cleavage of one to three cells is seen .
Previous research has assessed the relationship between embryo morphokinetics and embryo culture conditions (Basile et al., 2013) (Ciray et al., 2012) , and a number of female factors such as age (Hampl & St ep an, 2013) , ovarian reserve (Freour et al., 2012) , body mass index (Bellver et al., 2013) , type of ovarian stimulation (Muñoz et al., 2013) , and tobacco consumption (Lammers et al., 2015) (Fr eour et al., 2013) . However, very little is known about the influence of sperm parameters on embryo morphokinetics (Lammers et al., 2015) .
The aim of this study was to investigate if sDNAf has an impact on embryo development. In particular, we assessed its effect on the timings of cell cleavage, the blastocyst rate, the embryo cleavage patterns, and the percentage of good quality embryos. Results are analyzed by comparing the two possible sources of the oocyte (donated or the patient's own gamete) to assess whether oocyte quality modulates the impact of sDNAf on embryo morphokinetics.
MATERIAL AND METHODS

Patients
This retrospective study was carried out at a private, university-affiliated Reproductive Medicine & Fertility clinic in Barcelona, Spain. Written informed consent was obtained from all participants, and the study was approved by both an institutional review board and the Hospital Cl ınic de Barcelona's Clinical Research Ethics Committee (Code HCB/2015/0705).
Patients' inclusion criteria were the use of fresh ejaculated spermatozoa for an ICSI cycle and embryo culture in a TLM incubator (EmbryoScope â , Vitrolife, G€ oteborg, Sweden) until D+5 of development. Indications for ICSI were male infertility and/or the use of vitrified oocytes. Exclusion criterion was the presence of less than 2 9 10 6 /mL spermatozoa in the fresh sample. Patients using their own oocytes and those who received them through the oocyte donation program were included. Oocyte donation was anonymous and altruistic. The potential gamete donors were recruited from young (<35 years old) volunteers. Details of donor selection and work-up studies have been previously reported (Garrido et al., 2002) .
Ovarian stimulation and oocyte retrieval
Ovarian stimulation in patients and donors was carried out with recombinant FSH (Puregon, MSD, Madrid, Spain; and Gonal-F; MerckSerono, Geneva, Switzerland) or human menopausal gonadotropin (Menopur; Ferring Pharmaceuticals, Copenhagen, Denmark), with initial daily doses ranging from 698 Andrology, 2018, 6, 697-706 150 IU to 225 IU. A flexible GnRH antagonist protocol was used (Cetrotide; MerkSerono; and Orgalutran; MSD), with daily 0.25 mg initiated on day 5 or 6 of stimulation. Recombinant hCG (Ovitrelle; MerkSerono) was administered as soon as two leading follicles reached a mean diameter of 17 mm, and oocyte retrieval was scheduled to occur 36 h later.
Sperm collection and density gradient centrifugation
Semen samples were collected by masturbation into non-toxic sterile plastic jars after 3-5 days of sexual abstinence. Time of sperm collection was adjusted to the moment that oocytes had to be microinjected in order to minimize the possible effect of ROS. Samples were allowed to liquefy for 30 min at room temperature (22°C) and evaluated according to the WHO criteria (World Health Organization 2010 was stratified on top of the discontinuous gradient columns and centrifuged for 18 min at 300 g. After centrifugation, the pellet obtained was collected and washed twice at 350 g for 5 min. After DGC, a second evaluation of sperm parameters was carried out and the prepared samples were used for the microinjection of the oocytes. Once the microinjection was performed, one aliquot of the processed spermatozoa was fixed with 4% paraformaldehyde and stored at 4°C until sDNAf analysis was carried out.
DNA fragmentation assessment
In situ Cell Death Detection Kit (Roche Diagnostics, Barcelona, Spain) based on the TdT (terminal deoxynucleotidyl transferase)-mediated dUDP nick-end labeling (TUNEL) assay was used according to the manufacturer's instructions to quantify the sDNAf of sperm samples after DGC. Samples were washed with phosphate-buffered saline (PBS) (Gibco; Invitrogen, Barcelona, Spain). There was an incubation step in permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) for 2 min at 4°C. Samples were incubated for 1 h at 37°C with TUNEL reaction-mixture label solution and terminal transferase solution. Each experimental setup also included a positive control, where the sample was incubated with 3 IU/mL DNase I recombinant in 50 mmol/L Tris-HCl, pH 7.5 (Roche Diagnostics) for 15 min at 25°C to induce DNA fragmentation prior to labeling procedures, and a negative control without the enzyme solution. Samples were washed twice in PBS for 3 s at 7200 g, and PBS was added for a final volume of 1 mL. Damage quantification was performed on at least 10,000 cells in a FACScan (Becton Dickinson, Franklin Lakes, NJ, USA) cytometer at 488 nm wavelength of fluorescence intensity.
IVF laboratory procedures and cycle outcomes
After follicular aspiration, cumulus-oocyte complexes were isolated, and extensively washed in Global Total with HEPES medium (LifeGlobal) covered with LifeGuard oil (LifeGlobal). The cumulus-oocyte complexes were then cultured in Global Total for Fertilization medium (LifeGlobal). Approximately 4 h after oocyte retrieval, oocytes were denuded from cumulus cells by mechanical pipetting in 80 IU/mL hyaluronidase (LifeGlobal) and washed thoroughly. Intracytoplasmic sperm injection (ICSI) was subsequently performed on all metaphase II oocytes at 400 magnification using an Olympus IX71 inverted microscope in manipulation medium. Afterward, the microinjected oocytes were washed in culture medium and distributed in the EmbryoSlides â , and embryos were cultured until day 5 (D5) of development. The EmbryoScope (Vitrolife, Sweden) incubators were set with 6.8% CO2 and 7% O2 to achieve a controlled pH value within the 7.22-7.28 range, which was routinely monitored on a weekly basis. The blastocyst arrival rate was obtained by dividing the number of blastocysts by the number of zygotes. An embryo was considered of good quality when it was a 2BB or better, according to Gardner classification (Gardner & Balaban, 2016) . The rate of good quality embryos was calculated as transferred and frozen embryos divided by the number of zygotes. A rise in serum ß-HCG concentration 14 days after transfer indicated pregnancy. A clinical pregnancy was considered when at least one intrauterine sac was revealed by ultrasonography approximately 3 weeks after transfer. The implantation rate was calculated as the ratio of gestational sacs determined by ultrasound in relation to the total number of embryos replaced. Miscarriage was defined as a spontaneous pregnancy loss after an intrauterine pregnancy had been detected by ultrasound. The live birthrate was calculated by dividing the number of patients achieving a delivery by the number of patients undergoing a replacement.
Time-lapse imaging and assessment
Images were recorded automatically in seven focal planes every 10 min. A time-point was automatically assigned to each image reported as hours after time zero (t0), which was defined as the time of injecting the spermatozoa into the oocyte. Manual annotation of time-lapse images was performed at an external workstation (Embryo Viewer TM ). Nomenclature and documentation of embryo developmental events were done following proposed guidelines (Ciray et al., 2014) . Kinetic parameters measured in the present analysis were as follows: time of extrusion of the second polar body (tPB2), time of pronucleous appearance (tPNa), time of pronucleous fading, and time of first division to 2-(t2), 3-(t3), 4-(t4), 5-(t5), 9-(t9) cells. Time to reach the morula stage (tM), to start the formation of a blastocoel (tSB), to full blastocoel formation (tB), and to blastocyst expansion (tEB) were also registered. Moreover, the duration of events including the second cell cycle (cc2 = t3-t2), the third cell cycle (cc3 = t5-t3), the second synchrony (s2 = t4-t3), and the interval between two and five cells (t5-t2) were also calculated.
Grading of embryos (A, B, C, D, or E) was performed according to a validated classification algorithm (Basile et al., 2015) . The two morphological features scored were as follows: uneven blastomere size at the two-cell stage during the interphase when the nuclei are visible (blastomere size was considered uneven if the average diameter of the large blastomere was 25% larger than the average diameter of the small blastomere), and multinucleation at the four-cell stage during the interphase when the nuclei are visible.
Five abnormal cleavage patterns were documented: direct cleavage from a single cell to three cells; direct cleavage from a single cell to four cells; incomplete cleavage; reverse cleavage, which is the reduction in the number of blastomeres due to the fusion of cells; and asynchronous cleavage, registered when the daughter cell cleaved before the original one.
When the evaluation of specific events was not possible due to unfocused imaging or technical problems, these data points were treated as missing data.
Statistical analysis
Data were analyzed using IBM SPSS Statistics for WINDOWS, version 22 (IBM Corp., Armonk, NY, USA). Statistical significance was defined as p < 0.05.
The time of each cell cleavage and irregular division, such as direct cleavage, incomplete cleavage, reverse cleavage, and asynchronous cleavage, was documented and correlated with sDNAf. All continuous variables (morphokinetics and DNA fragmentation) presented normal distributions. Continuous parameters between two or more groups were statistically analyzed using a multifactorial analysis of variance (ANOVA) model.
For statistical analysis, sDNAf was categorized into quartiles (≤6.50 (n = 242); 6.51-10.70 (n = 239); 10.71-20.15 (n = 251); and >20.15 (n = 239)). This procedure avoided bias due to differences in the total number of sDNAf levels in each category. Chi-square tests were used to make comparisons between categorical data. We compared the morphokinetics of embryo development between the donated and own oocyte groups depending on sDNAf quartiles using an ANOVA test.
The correlation between the level of sDNAf and the percentage of embryos reaching the blastocyst stage and the rate of good quality embryos per cohort was also assessed. As previously described, embryos were graded in five categories (A, B, C, D, or E) according to a validated classification algorithm (Basile et al., 2015) and mean sDNA fragmentation of semen samples according to embryo category was compared for statistical significance between them using ANOVA. Data were compared in the overall sample and also compared separately for cycles in which own oocytes or donated oocytes were used.
To study the association between sDNAf and cycle outcome, cycles were divided into two groups according to the result of the sperm test, using 20% as the cutoff point (Sergerie et al., 2005) .
Our calculations of sample size were based on the number of embryos analyzed, considering the effect of sDNAf on embryo morphokinetics hypothesis and using a 1.2-h difference for cc2. We determined the sample size required to be 220 embryos per quartile group using a risk alpha 0.05 and power 80%.
RESULTS
Causes of infertility in the 56 cases of fertilization with own oocytes were as follows: advanced maternal age in 16 cases, low ovarian response in 12, idiopathic infertility in ten, tubal factor in six, endometriosis in five, male factor in five, and ovarian factor in two. Indications for egg donation in the 79 cases of fertilization with donor oocytes included advanced maternal age in 58 cases, previous assisted reproduction treatment failure in five, ovarian failure in four, genetic disease in three, endometriosis in three, menopause in three, low ovarian response in two, and adnexectomy in one case.
In the patient's own oocytes group, 552 fresh and 13 thawed eggs were used, 420 MII were microinjected and 327 were correctly fertilized. In the oocyte recipients group, a total of 306 fresh and 760 thawed oocytes were donated, 879 were microinjected, and 644 zygotes were obtained. All of the 971 embryos were cultured until D + 5.
Mean sDNAf observed in the neat samples used for the ICSI cycles was 14.30 AE 10.52% (mean AE standard deviation). Neither the origin of oocytes nor whether they were fresh or vitrified was associated with sDNAf or sperm parameters. As expected, mean age and duration of infertility were higher in couples undergoing oocyte donation cycles (Table 1) . Interestingly, we found that embryos derived from donated oocytes showed slower divisions in the upper quartile of sDNAf. The difference was statistically significant for tPB2, tPNa, t2, t3, t4, t5, t6, t7, t9, tM, and t5-t2 (Table 2 ). These findings were not observed in embryos from cycles in which the patient's own oocytes were used (Table 3) .
We compared the timings of all TLM variables considered between donor and own oocytes (each of them considered as a single group), and there were no significant differences. Then, we repeated the comparisons for each sDNAf quartiles (≤6.50; 6. 51-10.70; 10.71-20.15; and >20.15) . Interestingly, only in the latter group did significant differences appear between some of the TLM timings between own and donated oocytes (Table 4) .
Regarding embryo cleavage pattern, normal cleavage was observed in 740 embryos (76.21%), direct cleavage from 1 to 3 blastomeres in 104 embryos (10.71%), direct cleavage from 1 to 4 blastomeres in 12 embryos (1.13%), incomplete cleavage in 44 embryos (4.53%), reverse cleavage in 42 embryos (4.32%), and asynchronous cleavage in 29 embryos (2.99%). The cleavage pattern was independent of the percentage of SDNAf, which was, on average, 14.26 AE 10.52, 13.64 AE 8.75, 16.28 AE 11.65, 14.54 AE 13.93, and 12.64 AE 9.55 in each of the groups, respectively. When looking only at cases using the patient's own oocytes, the cleavage pattern remained independent of the percentage of sDNAf, which was, average, 15.89 AE 9.67, 9.78 AE 5.22, 12.29 AE 9.08, 12.17 AE 8.64, and 14.60 AE 9.31 for each group, respectively. The same was seen in oocyte donation cycles, with an average percentage of sDNAf of 16.33 AE 14.42, 18.53 AE 18.01 12.90 AE 8.59, 13.00 AE 11.41, and 10.05 AE 5.68 for each cleavage pattern group, respectively.
Regarding embryo development, the global blastocyst arrival rate was 63.0% (blastocysts divided by the number of zygotes), with the percentage of sDNAf being similar in embryos that did and did not blastulate (13.80 AE 10.27% vs. 14.65 AE 11.12%). The global rate of viable blastocyst (calculated as transferable and frozen blastocysts divided by the number of zygotes) was 45.49%, and this parameter was not related to the level of sDNAf.
Concerning morphokinetic parameters, 289 embryos were categorized as grade A (29.76%), 110 as grade B (11.33%), 118 as grade C (12.15%), 117 as grade D (12.05%), and 337 as grade E (34.71%). This classification was independent of sDNAf ( Fig. 1) .
Overall fertilization rate, pregnancy rate, implantation rate, and miscarriage rate were 78.60%, 61.42%, 44.09%, and 10.24%, respectively. When separated into two groups according to the source of the female gamete (own or donated oocytes), no significant differences in clinical outcome were observed when sDNAf was below or above 20% (Table 5 ).
In the own oocytes group (n = 56), no replacement was performed in four cases because embryos were vitrified, while single embryo transfer (SET) was performed in 13 cases and double 700 Andrology, 2018, 6, 697-706 embryo transfer (DET) in 39. In the oocyte recipients group (n = 79), no replacement was performed due to bad embryo quality (n = 3) or because embryos were vitrified (n = 1), while 27 and 48 underwent SET and DET, respectively. Variables such as the number of microinjected oocytes and the number of replaced embryos were also comparable in the two ranges of sDNAf.
The overall sDNAf in patients achieving clinical pregnancy vs. no pregnancy was 15.53 vs. 12.54, respectively (p = 0.303). The effect of sDNAf on clinical pregnancy rate had an odds ratio of 1.02 (IC95% 0.98-1.06).
DISCUSSION
In the present study, we observed that sDNAf influenced embryo morphokinetics, but did not determine final embryo quality. To our knowledge, this is the first study showing that a very high rate of sDNAf can delay embryo cleavage when donated oocytes are used.
Since the introduction of sDNAf as a test for sperm quality (Evenson et al., 1999) , the association between sperm DNA integrity and reproductive outcome has been assessed by many authors. One way to investigate whether sDNAf has any relevance as a biomarker for sperm quality is the detailed analysis of the embryos generated from spermatozoa with highly fragmented DNA. In the present work, we show that even samples with high sDNAf do not condition either the blastulation rate or the clinical outcome.
It is still controversial whether sDNAf can predict ART outcomes. One recent meta-analysis (Cissen et al., 2016) concluded that there was insufficient evidence to recommend the routine use of sperm DNA fragmentation tests in couples undergoing ART for either the prediction of pregnancy or the choice of treatment. However, another study found substantial evidence in the existing literature, suggesting that sperm DNA damage had a negative effect on clinical pregnancy following IVF and/or ICSI treatment (Simon et al., 2010) .
One potential source of misinterpretation in these reviews must be highlighted: Studies relating sDNAf and ART outcome are mainly focused on pregnancy achievement, while pregnancy loss has been described as the main negative effect of sperm DNA damage. According to this line of thought, sperm DNA integrity is not actually associated with morphological abnormalities at the zygote and early cleavage stages, but rather to effects at later stages (Zini et al., 2008) (Tesarik et al., 2004) (Borini et al., 2006) , such as first-trimester miscarriages (Carrell et al., 2003 ) (Ribas-Maynou et al., 2014 . In our study, no significantly increased miscarriage rate was observed in cycles with high sDNAf. However, clinical results were not the primary outcome of our study, and so the influence of a small sample size on the statistical power for such assessment cannot be ruled out. Some authors state that the effect of sDNAf on ART outcome may depend on the type of method used to measure sDNAf. In this study, the TUNEL assay was used to quantify sDNAf for two reasons: It is a direct method and it detects the damage by flow cytometry, enabling the fast assessment of many spermatozoa.
Recent studies state that TUNEL assay is the most simple and sensitive technique for measuring sDNAf (Cho et al., 2017) . It is reproducible when utilizing a standardized staining protocol and flow cytometer acquisition settings (Ribeiro et al., 2017) , and it is reliable and accurate as an additional diagnostic test in andrology laboratories (Selvam et al., 2018) .
Time-lapse technology has the potential to determine whether any intrinsic or extrinsic factor may affect early embryo behavior at the highest level, even if such effect does not condition reproductive outcome. To our knowledge, only two previous studies have assessed the relationship between sDNAf and embryo morphokinetics. In one of them, lower sDNAf was associated with faster blastocyst stage arrival (Wdowiak et al., 2015) . In the second study, higher sDNAf was related to lower mean time of tPNa and blastulation (in ICSI cycles) and higher tPNf and t2 (in IVF cycles) (Hambilik, 2016) . Although the second study is only available as an abstract, some methodological aspects seem to differ from our study. For example, the assessment of sDNAf was performed with the indirect SCSA method, only four timings were taken into consideration (time of formation and time of fading of pronuclei, time of early cleavage, and time of starting blastulation), and only patients using their own oocytes were included.
According to our data, embryos derived from spermatozoa with higher sDNAf and donated oocytes showed delayed cleavage division, a finding that may be the expression of a higher repairing capacity of oocytes provided from healthy donors, which can be time-consuming. Interestingly, the effect of sDNAf was only significant at higher levels, which may indicate that a lower oocyte DNA-repairing ability may be less relevant when sDNAf is low. Unfortunately, only a few publications assess basic information and new findings on DNA repair mechanisms. Experiments performed 30 years ago, however, demonstrated the ability of oocytes to repair damaged DNA: Non-replicating DNA plasmids irradiated with UV in vitro were rapidly repaired when injected into Xenopus oocytes (Hays et al., 1990) . Repair of DNA damage within the one-cell zygote, prior to the initiation of S phase of 702 Andrology, 2018, 6, 697-706 mitosis, is a critical step in the creation of viable embryos and healthy offspring. It is known that in the presence of oxidative lesions, such as 8-hydroxy-2 0 -deoxyguanosine (8OHdG) and G-C to T-A transversion, mutations can occur during DNA replication that not only alter the genetic profile of the zygote itself, but that also alter every cell generated by the rapid mitotic divisions that characterize embryogenesis (Lord & Aitken, 2015) . The cell division delay that we observed in our study has already been seen in mouse zygotes. One interesting study with mice found that 6-Gy-irradiated sperm zygotes could manage to synthesize a full DNA content by prolonging S phase by 2 h with respect to control zygotes (Shimura et al., 2002) . In another study, the first cell cycle was assessed in zygotes generated from spermatozoa induced to undergo chromatin fragmentation (SCF). Zygotes from spermatozoa with moderate DNA damage had both pronuclei replicating normally. However, paternal pronuclei in the SCF zygotes from spermatozoa with severe DNA damage delayed the initiation of DNA replication by up to 12 h, even though the maternal pronuclei had no discernible delay. The DNA replication delay caused a marked retardation in progression to the two-cell stage (Gawecka et al., 2013) . The authors suggested that the structure of the sperm chromatin is part of the mechanism that ensures the transmission of undamaged paternal DNA to the embryo by interacting with checkpoints in the first cell cycle, particularly at S phase. This reinforces the need to develop strategies for recognition of spermatozoa with abnormal chromatin packaging and/or sperm DNA damage that are frequently observed in infertile men.
To our knowledge, the higher repair capability of oocytes derived from healthy donors has never been addressed, but it is known that the effects of different intrinsic and extrinsic factors on the oocyte, from genetic background to aging, can affect the repairing activity of the zygote (Hamatani et al., 2004) . Higher mean quality of oocytes from young healthy donors in comparison with oocytes from infertile patients is indisputable. A vast body of the literature shows that the decline in ART outcome observed in women older than 35 years is completely overcome by the use of oocytes from donors bellow this age (Navot et al., 1991) . In our study, oocyte donation cycles obtained higher pregnancy and implantation rates than patients using their own oocytes, confirming that oocyte quality is better in young, healthy donors.
We used a TLM system to evaluate if sDNAf interferes with embryo cleavage. Previous publications evaluating human embryos using TLM systems have reported that aneuploid human embryos have a significantly delayed early development compared with euploid ones (Chavez et al., 2012) (Nogales et al., 2016) , with the same pattern observed at the periblastulation phase (Campbell et al., 2013) .
It should be noted that the observed effect may be even more relevant in cases where conventional IVF is performed. The laboratory protocol of ICSI includes a spermatozoa selection process based on morphology and motility, and a clear negative correlation has been established between these parameters (especially motility) and DNA fragmentation (Mahfouz et al., 2010) . One possible explanation for our study's lack of significant differences in implantation rate among groups of different sDNAf levels is the fact that a strict blastocyst selection process was established. We suspect that, if all cleavage stage embryos were replaced, significant differences in implantation rates would be observed. Regarding embryo quality, the fact that the blastocyst arrival rate was not influenced by sDNAf indicates that embryos with slow early cell divisions could latter catch up with the normal developmental rate.
Moreover, the influence of sDNAf is more pronounced in the later stages of embryo development (Tesarik et al., 2004) , suggesting that the best parameters for analyzing the impact of sDNAf on reproductive outcome are miscarriage and live birthrates. In our work, a significantly higher miscarriage rate was observed in the group of high sDNAf compared with low sDNAf with donor oocytes. In contrast, when the cycles performed with own oocytes were analyzed, no differences in miscarriage rate between high and low sDNAf groups were found, and the obtained values in both groups were similar to those of the high sDNAf group with donated oocytes. These results may be interpreted as a sign that the oocyte repairing machinery loses effectiveness with age, leading to a negative reproductive impact of even lower sDNAf.
One limitation of our study was the use of fresh and vitrified oocytes, although according to our data, this did not interfere with the variables measured. The retrospective nature of the analysis was another limitation, but a large database of embryos was studied.
In the current study, the delay observed in the morphokinetics of embryos generated from spermatozoa with high DNA fragmentation and donors' oocytes may result from the time taken by the female gametes to repair paternally inherited DNA. If this is the case, this could only occur because of the oocytes' high repair capacity. Such capacity cannot be assessed prior to an ART treatment, and there is no guarantee that sperm DNA impairment will be effectively overcome by the oocyte. The lack of delay in early cell divisions observed in embryos generated from the patients' own oocytes and sperm samples with high DNA fragmentation may indicate that such an exhaustive repairing process does not occur in these cases.
